Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium-Magnesium Citrate for Blood Pressure Lowering
NCT01074918Phase 2Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Sep 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of potassium citrate + magnesium citrate in hypertension (HTN) and prehypertension, sponsored by UT Southwestern Medical Center. Primary endpoint: Blood Pressure at 8 weeks. Planned start Sep 2009; status: withdrawn.
02
Drugs
potassium citrate + magnesium citrate
03
Conditions
hypertension (HTN)prehypertension
Beyond the preview
Go deeper on NCT01074918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01074918.